共 50 条
- [1] Reply to Kentaro Inamura's Letter to the Editor re: Mingxiao Feng, Andres Matoso, Gabriel Epstein, et al. Identification of Lineage-specific Transcriptional Factordefined Molecular Subtypes in Small Cell Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2023.05.023 [J]. EUROPEAN UROLOGY, 2024, 85 (04) : e122 - e123
- [6] Re: Zhiwen Chen, Peng He, Xiaozhou Zhou, et al. Preliminary Functional Outcome Following Robotic Intracorporeal Orthotopic Ileal Neobladder Suspension with Round Ligaments in Women with Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.012 [J]. EUROPEAN UROLOGY, 2022, 81 (05) : E118 - E118
- [7] Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j. eururo.2020.04.038 Cytoreductive Nephrectomy: To Whom and When? [J]. EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (04): : 559 - 560
- [8] Reply to Mattias Hoglund's Letter to the Editor re: Alexander Cox, Niklas Klumper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020 [J]. EUROPEAN UROLOGY, 2023, 84 (02) : E51 - E52
- [9] Re: Simpa S. Salami, Jeffrey J. Tosoian, Srinivas Nallandhighal, et al. Serial Molecular Profiling of Low-grade Prostate Cancer to Assess Tumor Upgrading: A Longitudinal Cohort Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.06.041 [J]. EUROPEAN UROLOGY, 2021, 79 (03) : E98 - E99